painreform.com - PRFX Company profit before taxes, interest and amortization
PainReform Ltd. (PRFX) management is focusing on refining formulas while currently generating no sales. The EBITDA figure as of today illustrates the results of this strategy, where the 0.00 level reflects the status of the parameter. The innovative drug PRF-110 reduces the need for opioids by providing a three-day effect. However, geopolitical instability and sanctions on raw materials create risks for supply chains and patent protection.
Summary analytical data breakdowns for PainReform (PRFX)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio PainReform Ltd.|PRFX - Long-Term Debt to Equity|Current Liabilities to Equity PainReform Ltd|PRFX - Company Aggregate Debts|Debts to Book Capitalization PainReform|PRFX - Company Long-Term Debts|Short-Term Debt Volume PainReform|Immediate Liquidity Ratio painreform.com
- earnings and market ratios statistics:
PRFX - Company Net Income|Expected Net Income PainReform Ltd.|PRFX - P/E Multiple|Projected Price to Earnings Ratio painreform.com|PRFX - PEG Multiple|Company Value to Operating Income Before Depreciation Ratio PainReform|PRFX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months PainReform|PRFX - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months painreform.com|PRFX - Earnings per share growth in current year|Expected earnings per share growth for next year PainReform Ltd.
Summary company analytics:PRFX (PainReform Corp)
PainReform Ltd. (PRFX) is developing long-acting analgesics for hospitals aimed at replacing opioids, which defines the potential for revenue scaling. An analysis of absolute operating profit allows for an assessment of the actual cash flow from these activities without the influence of debt load, while the absolute operating profit trend on this chart serves as an indicator of production asset efficiency across different cycle phases.
Who PainReform Ltd. competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|ANIP (ANI Pharmaceuticals Inc) - Profit before deduction of interest, taxes, depreciation and amortization|MannKind Corp. - Operating profit EBITDA|AMPH - Operating profit EBITDA|PCRX: Operating profit EBITDA|SPRY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Theravance Biopharma, Inc.|Operating profit before amortization AQST (Aquestive Therapeutics Inc)|Profit before payment of interest, taxes and amortization scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA TNXP (Tonix Pharmaceuticals)|SXT Pharmaceuticals (SXTC) - Profit before interest, taxes and amortization|Eupraxia Pharma - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization BHST|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Oramed Pharmaceuticals Inc. (ORMP)|Profit before payment of interest, taxes and amortization Entera Bio Ltd|HYFT: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ABVC BioPharma, Inc. (ABVC)|Operating profit before deduction of amortization Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization FGEN|TELO - Profit before payment of interest, taxes and amortization|RANI: Profit before payment of interest, taxes and amortization|SNYR (synergychc.com) - Operating profit before deduction of amortization|RLYB: Company profit before taxes, interest and amortization|LEXX (Lexaria Bioscience Corp) - Operating profit EBITDA|Operating profit before amortization PULM (Pulmatrix Corporation)|Operating profit before deduction of amortization PTHL (Pheton Holdings Ltd)|Operating income before deduction of amortization aptorumgroup.com|Profit before payment of interest, taxes and amortization Lyra Therapeutics LYRA|IBO (Impact BioMedical, Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|TNFA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization YCBD (cbdMD, Inc.)|CYTO: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization LIPO (lipella.com)|Operating profit before deduction of amortization OPTN|Operating profit before amortization PIRS (Pieris Pharmaceuticals Inc)|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|PTPI: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA QLI (Qilian International)|Income before deduction of interest, taxes and amortization SLRN|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
